Stem Cell Innovations Cites Johns Hopkins University Study As Growing Evidence Of Potential For Stem Cell Treatment Of Spinal Injuries

HOUSTON--(BUSINESS WIRE)--July 6, 2006--Stem Cell Innovations (OTCBB: SCLL - News), a cell biology company that has developed technology capable of creating a broad range of human cells from its patented, pluripotent stem cells, said today that it is heartened by the results reported by Johns Hopkins scientists in a study published last week (June 26, 2006) in “Annals of Neurology.” In the study, Dr. Douglas Kerr, of Johns Hopkins, reports that he and his team have engineered new, completed, fully working motor neuron circuits in paralyzed adult animals. In a video released the same day, the Johns Hopkins team shows a previously paralyzed rat - following stem cell transplantation 12 weeks earlier - regain its ability to walk again.

MORE ON THIS TOPIC